Related references
Note: Only part of the references are listed.Comparative proteomic study reveals the enhanced immune response with the blockade of interleukin 10 with anti-IL-10 and anti-IL-10 receptor antibodies in human U937 cells
Guoying Ni et al.
PLOS ONE (2019)
IL10 receptor is a novel therapeutic target in DLBCLs
W. Beguelin et al.
LEUKEMIA (2015)
Overexpressed oncogenic tumor-self antigens New vaccine targets
Robert K. Bright et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Clinical evaluation of therapeutic cancer vaccines
Chizuru Ogi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs
Jie Sun et al.
NATURE IMMUNOLOGY (2011)
Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
Louis M. Weiner et al.
CANCER PREVENTION RESEARCH (2010)
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice
Li-Xin Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
Taylor H. Schreiber et al.
SEMINARS IN IMMUNOLOGY (2010)
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF
Jennifer D. Lewis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: Prolonged survival
Saied Mirshahidi et al.
VACCINE (2009)
Regulation and functions of blimp-1 in T and B lymphocytes
Gisliine Martins et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Generation and Regulation of CD8+ Regulatory T Cells
Linrong Lu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52
Mona Shehata et al.
CLINICAL CANCER RESEARCH (2008)
Telomerase as a universal tumor antigen for cancer vaccines
Gregory L. Beatty et al.
EXPERT REVIEW OF VACCINES (2008)
Are CD8+CD122+ cells regulatory T cells or memory T cells?
Haruhiko Suzuki et al.
HUMAN IMMUNOLOGY (2008)
CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-αβTCR interaction and become IL-10-producing active regulatory cells
Muhaimin Rifa'i et al.
INTERNATIONAL IMMUNOLOGY (2008)
Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune
Young-Ho Lee et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses:: implications for immune function in aged mice
Akira Motegi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity
Laura A. Payton et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD8+ CD122+ T cells, a newly identified regulatory T subset, negatively regulate graves' hyperthyroidism in a murine model
Ohki Saitoh et al.
ENDOCRINOLOGY (2007)
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer
Yukiko Kiniwa et al.
CLINICAL CANCER RESEARCH (2007)
PrLZ is expressed in normal prostate development and in human prostate cancer progression
Ruoxiang Wang et al.
CLINICAL CANCER RESEARCH (2007)
The universal character of the tumour-associated antigen survivin
Mads Hald Andersen et al.
CLINICAL CANCER RESEARCH (2007)
Opinion - Are oncoantigens suitable targets for anti-tumour therapy?
Federica Cavallo et al.
NATURE REVIEWS CANCER (2007)
TH1 cells control themselves by producing interleukin-10
Anne O'Garra et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome
Panayiotis Loukopoulos et al.
CANCER SCIENCE (2007)
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52
Jennifer D. Lewis et al.
MOLECULAR CANCER RESEARCH (2007)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transcriptional repressor Blimp-1 regulates T cell homeostasis and function
GA Martins et al.
NATURE IMMUNOLOGY (2006)
Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
A Kallies et al.
NATURE IMMUNOLOGY (2006)
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
JA Byrne et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cutting edge:: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells
AT Endharti et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulatory T cells and mechanisms of immune system control
A O'Garra et al.
NATURE MEDICINE (2004)
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer
MA Rubin et al.
CANCER RESEARCH (2004)
Tumor-associated antigens: From discovery to immunity
JD Lewis et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2003)
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
AP Vicari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
